Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 23, 2020 07:15 ET | Source: MacroGenics, Inc.

MacroGenics Announces MGC018 Publication in Molecular Cancer Therapeutics

Manuscript describes preclinical development of MGC018Phase 1 dose expansion trial evaluating MGC018 in patients with mCRPC, TNBC and NSCLC is currently recruiting patients ROCKVILLE, MD,...